Anebulo Pharmaceuticals Q3 EPS $(0.06) Beats $(0.12) Estimate
Anebulo Pharmaceuticals Q3 EPS $(0.06) Beats $(0.12) Estimate
Anebulo Pharmaceuticals第三季度每股收益美元（0.06美元）超过预期（0.12美元）
Anebulo Pharmaceuticals (NASDAQ:ANEB) reported quarterly losses of $(0.06) per share which beat the analyst consensus estimate of $(0.12) by 50 percent. This is a 45.45 percent increase over losses of $(0.11) per share from the same period last year.
Anebulo Pharmicals（纳斯达克股票代码：ANEB）公布的季度亏损为每股0.06美元，比分析师普遍预期的0.12美元（0.12美元）高出50％。与去年同期的每股亏损（0.11）美元相比，增长了45.45％。
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。